ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO963

Improving Identification and Documentation of Urinary Tract Infection Risk after Renal Transplantation in Children

Session Information

Category: Transplantation

  • 1702 Transplantation: Clinical and Translational

Authors

  • Gaudreault-Tremblay, Marie-Michele, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Noone, Damien Gerard, The Hospital for Sick Children, Toronto, Ontario, Canada
  • McQuillan, Rory F., University of Toronto, Toronto, Ontario, Canada
  • Hebert, Diane, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Parekh, Rulan S., The Hospital For Sick Children, Toronto, Ontario, Canada
Background

Urinary tract infection (UTI) is the most frequent infectious complication after kidney transplantation in children. Trimethoprim-Sulfamethoxazole is standard UTI prophylaxis in all transplant recipients, irrespective of pre-transplant diagnosis or post-transplantation UTI risk factors. Identification and documentation of patient’s risk of post-transplantation UTI is often lacking, which complicates the choice of appropriate prophylaxis. The aim of this quality improvement project is to improve documentation and categorization of post-transplantation UTI risk for transplant recipients, with a target screening rate of 90%.

Methods

In our Centre, the model for improvement (Plan-Do-Study-Act) was used to sequentially implement an educational initiative and a checklist to facilitate systematic review of UTI history and risk factors. The purpose of the intervention was to allow clinicians to categorize children’s post-transplantation UTI risk. Documentation in patients’ medical records was assessed at each clinic visit. Parameters analyzed were: appropriate identification/documentation of post-transplantation UTI risk, UTI history and risk factors. The medical team satisfaction regarding the intervention and the supplementary time used to document was also assessed. A u chart was used for analysis.

Results

A total of 14 renal transplant outpatient clinics (77 patients; 126 medical visits) were reviewed from February to May 2017. The baseline documentation of UTI history in the patient’s medical record was 45% and of UTI risk factors 25%. After the medical team educational session, an increase of the documentation of UTI risk factors was observed (47% of documentation following educational session) but no significant change in documentation of UTI history (41%). Following implementation of the checklist, documentation of UTI history and risk factors improved by 21% and 17% respectively. However, categorization of patient’s post-transplantation UTI risk was almost always missing.

Conclusion

UTI is a major clinically significant complication following pediatric kidney transplantation. Implementation of a checklist significantly improved documentation of UTI history and risk factors in children after renal transplantation.